Evidence map›Paper›PMID 23399853›Full record

ArticleLaboratory investigation; a journal of technical methods and pathology2013

Quantitation of fixative-induced morphologic and antigenic variation in mouse and human breast cancers.

Robert D Cardiff, Neil E Hubbard, Jesse A Engelberg, Robert J Munn, Claramae H Miller, Judith E Walls, Jane Q Chen, Héctor A Velásquez-García, Jose J Galvez, Katie J Bell and 3 more

Abstract readComparative Study
In one paragraph

Article in Laboratory investigation; a journal of technical methods and pathology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
8.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Tumor-specific delivery of gemcitabine with activatable liposomes.Journal of controlled release : official journal of the Controlled Release Society · 2019
    Article
  5. Combining activatable nanodelivery with immunotherapy in a murine breast cancer model.Journal of controlled release : official journal of the Controlled Release Society · 2019
    Article
  6. A Syngeneic ErbB2 Mammary Cancer Model for Preclinical Immunotherapy Trials.Journal of mammary gland biology and neoplasia · 2019
    Article
  7. Article
  8. CD8Clinical cancer research : an official journal of the American Association for Cancer Research · 2018
    Article
  9. Principles and approaches for reproducible scoring of tissue stains in research.Laboratory investigation; a journal of technical methods and pathology · 2018
    Review
  10. Article
  11. Article
  12. Pathobiology of the 129:Stat1Breast cancer research : BCR · 2017
    Article
  13. Article
  14. Article
  15. Intracellular trafficking of a pH-responsive drug metal complex.Journal of controlled release : official journal of the Controlled Release Society · 2016
    Article
  16. Article
  17. Article
  18. 184AA3: a xenograft model of ER+ breast adenocarcinoma.Breast cancer research and treatment · 2016
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Robert D CardiffCenter for Comparative Medicine, University of California, Davis, CA 95616, USA.
Neil E Hubbard
Jesse A Engelberg
Robert J Munn
Claramae H Miller
Judith E Walls
Jane Q Chen
Héctor A Velásquez-García
Jose J Galvez
Katie J Bell
Laurel A Beckett
Yue-Ju Li
Alexander D Borowsky
University of California, Davis · USNational Cancer Institute · US

Funding

Staff InvestigatorsP30CA093373 · NCI · UNIVERSITY OF CALIFORNIA DAVIS · PI Laura Marcu · 2002 to 2026
$84.9M
UC DAVIS CLINICAL AND TRANSLATIONAL SCIENCE CENTER: BPCAUL1RR024146 · NCRR · UNIVERSITY OF CALIFORNIA AT DAVIS · PI BERGLUND, LARS F · 2006 to 2011
$27.0M
Mechanisms of breast cancer progressionU01CA105490 · NCI · UNIVERSITY OF PENNSYLVANIA · PI CHODOSH, LEWIS A · 2004 to 2013
$6.7M
Translational Insights into Estrogen Receptor alpha-Positive Luminal Breast CanceU01CA141541 · NCI · WASHINGTON UNIVERSITY · PI CARDIFF, ROBERT D, SCHREIBER, ROBERT DAVID · 2009 to 2013
$3.8M
The Center for Translational Genomic PhenotypingU01CA141582 · NCI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI CARDIFF, ROBERT D, CHERRY, SIMON R · 2009 to 2013
$3.5M
NCI NIH HHS P30 CA093373NCI NIH HHS U01 CA105490NCI NIH HHS U01 CA105490-01NCI NIH HHS U01 CA141541NCI NIH HHS U01 CA141582NCRR NIH HHS UL1 RR024146
6 · The paper itself

Abstract

Quantitative Image Analysis (QIA) of digitized whole slide images for morphometric parameters and immunohistochemistry of breast cancer antigens was used to evaluate the technical reproducibility, biological variability, and intratumoral heterogeneity in three transplantable mouse mammary tumor models of human breast cancer. The relative preservation of structure and immunogenicity of the three mouse models and three human breast cancers was also compared when fixed with representatives of four distinct classes of fixatives. The three mouse mammary tumor cell models were an ER+/PR+ model (SSM2), a Her2+ model (NDL), and a triple negative model (MET1). The four breast cancer antigens were ER, PR, Her2, and Ki67. The fixatives included examples of (1) strong cross-linkers, (2) weak cross-linkers, (3) coagulants, and (4) combination fixatives. Each parameter was quantitatively analyzed using modified Aperio Technologies ImageScope algorithms. Careful pre-analytical adjustments to the algorithms were required to provide accurate results. The QIA permitted rigorous statistical analysis of results and grading by rank order. The analyses suggested excellent technical reproducibility and confirmed biological heterogeneity within each tumor. The strong cross-linker fixatives, such as formalin, consistently ranked higher than weak cross-linker, coagulant and combination fixatives in both the morphometric and immunohistochemical parameters.

Indexed as

AnimalsAntigenic VariationBiomarkers, TumorCell Line, TumorFemaleFixativesHumansImmunohistochemistryLiverMammary Neoplasms, ExperimentalMiceMice, 129 StrainReproducibility of ResultsSpecimen HandlingBiomarkers, TumorFixatives

Identifiers

PMID23399853
PMCPMC3843496
OpenAlexW2081507223

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.